Nascent Biotech, Inc. filed its 10-K/A on Jul 03, 2023 for the period ending Mar 31, 2023. In this report its auditor, Fruci & Associates II, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0948 USD | +5.33% | -5.01% | -45.17% |
1st Jan change | Capi. | |
---|---|---|
-45.17% | 1.62Cr | |
+9.42% | 11TCr | |
+11.84% | 11TCr | |
-1.05% | 2.2TCr | |
-14.15% | 2.18TCr | |
-5.29% | 1.92TCr | |
-4.16% | 1.81TCr | |
-38.29% | 1.77TCr | |
+7.99% | 1.43TCr | |
+36.24% | 1.24TCr |
- Stock Market
- Equities
- NBIO Stock
- News Nascent Biotech, Inc.
- Nascent Biotech, Inc. Auditor Raises 'Going Concern' Doubt